These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 810794)

  • 1. [Effect of mycobacteriophages on the course of experimental tuberculosis in albino mice].
    Koz'min-Sokolov BN; Vabilin
    Probl Tuberk; 1975; (4):75-9. PubMed ID: 810794
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of mycobacteriophages in experimental tuberculosis].
    Gel'berg SI; Sharov GI
    Probl Tuberk; 1975; (4):70-4. PubMed ID: 810793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Virulence of H37RV cultures treated with mycobacteriophages].
    Balakleevskaia AA; Kosobutskiĭ LA
    Probl Tuberk; 1978 Jun; (6):77-9. PubMed ID: 97663
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in the lytic spectrum and antigenic properties of mycobacteriophages after passages on Mycobacterium tuberculosis and other mycobacteria.
    Kosobutsky LA
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(1):42-9. PubMed ID: 4139192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of mycobacteriophages on the specific activity of BCG vaccine in an experiment].
    Sharov GI; Gel'berg SI
    Probl Tuberk; 1973; 51(8):70-3. PubMed ID: 4584752
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection.
    Palendira U; Spratt JM; Britton WJ; Triccas JA
    Vaccine; 2005 Feb; 23(14):1680-5. PubMed ID: 15705472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacteriophages and phage typing.
    Engel HW
    Ann Microbiol (Paris); 1978 Jan; 129(1):75-90. PubMed ID: 418716
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study of the PH phage susceptibility of M. tuberculosis isolated from tuberculosis patients (author's transl)].
    Sushida K; Osada F
    Kekkaku; 1976 Jan; 51(1):13-7. PubMed ID: 815709
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of resistance to tuberculosis in mice with defined components of Mycobacteria and with some unrelated materials.
    Ribi E; Granger DL; Milner KC; Yamamoto K; Strain SM; Parker R; Smith RW; Brehmer W; Azuma I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):345-56. PubMed ID: 6805154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.
    Broxmeyer L; Sosnowska D; Miltner E; Chacón O; Wagner D; McGarvey J; Barletta RG; Bermudez LE
    J Infect Dis; 2002 Oct; 186(8):1155-60. PubMed ID: 12355367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental tuberculous infection produced by the system phage-Mycobacterium].
    Kosobutskiĭ LA; Sharov GI; Balakleevskaia AA
    Probl Tuberk; 1974; 52(5):63-7. PubMed ID: 4211266
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs.
    Kahnert A; Höpken UE; Stein M; Bandermann S; Lipp M; Kaufmann SH
    J Infect Dis; 2007 Jan; 195(1):46-54. PubMed ID: 17152008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis.
    Seiler P; Aichele P; Raupach B; Odermatt B; Steinhoff U; Kaufmann SH
    J Infect Dis; 2000 Feb; 181(2):671-80. PubMed ID: 10669354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phage amplified biologically assay and its application in rapid detection of Mycobacterium tuberculosis].
    Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):850-2. PubMed ID: 15730788
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis: the genetics of vulnerability.
    Jabado N; Gros P
    Nature; 2005 Apr; 434(7034):709-11. PubMed ID: 15815612
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
    Sambandamurthy VK; Derrick SC; Hsu T; Chen B; Larsen MH; Jalapathy KV; Chen M; Kim J; Porcelli SA; Chan J; Morris SL; Jacobs WR
    Vaccine; 2006 Sep; 24(37-39):6309-20. PubMed ID: 16860907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of immunobiological properties of specific immunomodulators of the adjuvant type in experimental tuberculosis].
    Gorelova LA; Zemskova ZS; Panasek IA; Nekrasov AV; Puchkova NG; Moroz AM; Romanova RIu
    Probl Tuberk; 1996; (3):46-7. PubMed ID: 8754882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subdivision of M. tuberculosis by means of bacteriophages. With special reference to epidemiological studies.
    Baess I
    Acta Pathol Microbiol Scand; 1969; 76(3):464-74. PubMed ID: 4980863
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41.
    Skeiky YA; Alderson MR; Ovendale PJ; Lobet Y; Dalemans W; Orme IM; Reed SG; Campos-Neto A
    Vaccine; 2005 Jun; 23(30):3937-45. PubMed ID: 15917115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacteriophages as versatile tools for genetic manipulation of mycobacteria and development of simple methods for diagnosis of mycobacterial diseases.
    Stella EJ; de la Iglesia AI; Morbidoni HR
    Rev Argent Microbiol; 2009; 41(1):45-55. PubMed ID: 19391526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.